Stephen Hahn, AP

August 27, 2020 06:52 AM EDTUpdated 10:20 AM

FDA commish Hahn spotlights Oct 22 vaccine advisory meeting as the next big flashpoint in the Covid-19 campaign

John Carroll

Editor & Founder

Mark October 22 on your calendars if you want to watch the next big controversy over the rapid-fire development of Covid-19 vaccines play out at …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE LOG IN

ENDPOINTS CAREERS

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA

view job offer post your job now

TRENDING NOW

Trump asks 'very tough hombre' Dr. Oz to lead MFN talks

Endpoints 100 biotech survey: Welcome to the summer of biotech’s discontent

US warns drugmakers against misrepresenting cost of imported products

About 5% of CBER and CDER left after FDA staff cuts, analysis finds

Meet the ‘first sale’ rule: A customs loophole pharma companies could use to ease tariff impact

sponsored

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?